Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Usefulness of the Intersocietal Accreditation Commission (IAC) Quality Improvement Self-assessment Tool After 1 Year.

Farrell MB, Lally M, Vermeiren F.

Qual Manag Health Care. 2019 Jul/Sep;28(3):163-168. doi: 10.1097/QMH.0000000000000214.

PMID:
31246779
2.

Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test.

Jagodzinski LL, Manak MM, Hack HR, Liu Y, Malia JA, Freeman J, Phanuphak N, de Souza M, Kroon ED, Colby DJ, Chomchey N, Lally MA, Michael NL, Ananworanich J, Peel SA; RV254/SEARCH010 Study Team.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01922-18. doi: 10.1128/JCM.01922-18. Print 2019 May.

3.
4.

HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.

Mullins TLK, Zimet G, Lally M, Xu J, Thornton S, Kahn JA.

AIDS Patient Care STDS. 2017 Dec;31(12):504-516. doi: 10.1089/apc.2017.0147.

5.

A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.

Gamarel KE, Nichols S, Kahler CW, Westfall AO, Lally MA, Wilson CM; Adolescent Medicine Trials Network for HIV/AIDS Intervention.

Sex Transm Infect. 2018 Jun;94(4):304-308. doi: 10.1136/sextrans-2017-053334. Epub 2017 Nov 27.

6.

Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.

Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, Gorbach P.

AIDS Behav. 2018 Apr;22(4):1174-1183. doi: 10.1007/s10461-017-1958-4.

7.

Partner Notification for Youth Living With HIV in 14 Cities in the United States.

van den Berg JJ, Javanbakht M, Gorbach PM, Rudy BJ, Westfall AO, Wilson CM, Lally MA; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):46-52. doi: 10.1097/QAI.0000000000001565.

8.

HIV Continuum of Care for Youth in the United States.

Lally MA, van den Berg JJ, Westfall AO, Rudy BJ, Hosek SG, Fortenberry JD, Monte D, Tanney MR, McFarland EJ, Xu J, Kapogiannis BG, Wilson CM; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN).

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):110-117. doi: 10.1097/QAI.0000000000001563.

9.

Tobacco Use and Sustained Viral Suppression in Youth Living with HIV.

Gamarel KE, Westfall AO, Lally MA, Hosek S, Wilson CM; Adolescent Medicine Trials Network for HIV/AIDS Intervention.

AIDS Behav. 2018 Jun;22(6):2018-2025. doi: 10.1007/s10461-017-1915-2.

10.

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.

Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM.

JAMA Pediatr. 2017 Nov 1;171(11):1063-1071. doi: 10.1001/jamapediatrics.2017.2007.

11.

Effect of Facility IAC-Accreditation on CT Dose Awareness and Reduction.

Farrell MB, Lally M, Merrill N, Pizzutiello R, Setzen G, Choi JY.

Radiol Technol. 2017 May;88(5):472-480.

PMID:
28500090
12.

Effectiveness and Side Effect Profile of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder in Youth with Epilepsy.

Kral MC, Lally MD, Boan AD.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):735-740. doi: 10.1089/cap.2016.0186. Epub 2017 Apr 6.

PMID:
28383998
13.

A genetic marker of risk in HIV-infected individuals with a history of hazardous drinking.

Barker DH, Nugent NR, Delgado JR, Knopik VS, Brown LK, Lally MA, McGeary JE.

AIDS Care. 2017 Sep;29(9):1186-1191. doi: 10.1080/09540121.2017.1291898. Epub 2017 Feb 21.

14.

Avatar Web-Based Self-Report Survey System Technology for Public Health Research: Technical Outcome Results and Lessons Learned.

Authors, Savel C, Mierzwa S, Gorbach PM; Dr.P.H, Souidi S, Lally M; MD, Zimet G; Ph.D; Adolescent Medicine Trials Network for HIV, Interventions A.

Online J Public Health Inform. 2016 Sep 15;8(2):e189. doi: 10.5210/ojphi.v8i2.6719. eCollection 2016.

15.

An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Mulligan K, Zimet G, Lally M, Mayer KH, Anderson P, Kiser J, Rooney JF, Wilson CM; Adolescent Trials Network (ATN) for HIVAIDS Interventions.

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29.

16.

Identification of ADHD in youth with epilepsy.

Kral MC, Lally MD, Boan AD.

J Pediatr Rehabil Med. 2016 Sep 2;9(3):223-9. doi: 10.3233/PRM-160383.

PMID:
27612082
17.

State-civil society partnerships for HIV/AIDS treatment and prevention in Ghana: exploring factors associated with successes and challenges.

Hushie M, Omenyo CN, van den Berg JJ, Lally MA.

BMC Health Serv Res. 2016 Aug 2;16:332. doi: 10.1186/s12913-016-1598-9.

18.

Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication.

Li M, Tucker LD, Asara JM, Cheruiyot CK, Lu H, Wu ZJ, Newstein MC, Dooner MS, Friedman J, Lally MA, Ramratnam B.

J Clin Invest. 2016 Aug 1;126(8):3117-29. doi: 10.1172/JCI82360. Epub 2016 Jul 25.

19.

Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.

Mullins TL, Zimet G, Lally M, Kahn JA.

AIDS Patient Care STDS. 2016 Jul;30(7):339-48. doi: 10.1089/apc.2016.0048.

20.

Not All Generic Concerta Is Created Equal: Comparison of OROS Versus Non-OROS for the Treatment of ADHD.

Lally MD, Kral MC, Boan AD.

Clin Pediatr (Phila). 2016 Nov;55(13):1197-1201. Epub 2015 Oct 14.

PMID:
26467563

Supplemental Content

Loading ...
Support Center